Estonia - Estonia - Ravimiamet

desitin arzneimittel gmbh - valproehape - gastroresistentne tablett - 300mg 100tk; 300mg 50tk

Estonia - Estonia - Ravimiamet

g.l. pharma gmbh - valproehape - suukaudsed tilgad, lahus - 300mg 1ml 100ml 1tk

Estonia - Estonia - Ravimiamet

sanofi winthrop industrie - valproehape - toimeainet prolongeeritult vabastav tablett - 300mg 100tk

Estonia - Estonia - Ravimiamet

ideal trade links uab - valproehape - toimeainet prolongeeritult vabastav tablett - 500mg 100tk; 500mg 30tk

Estonia - Estonia - Ravimiamet

g.l. pharma gmbh - valproehape - siirup - 50mg 1ml 100ml 1tk

Estonia - Estonia - Ravimiamet

g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 500mg 100tk

Estonia - Estonia - Ravimiamet

g.l. pharma gmbh - valproehape - toimeainet prolongeeritult vabastav tablett - 300mg 100tk; 300mg 50tk

Estonia - Estonia - Ravimiamet

g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 300mg 100tk

Estonia - Estonia - Ravimiamet

g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 150mg 100tk

Kesatuan Eropah - Estonia - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.